Clinical Trial
RNS System LGS Feasibility Study
ClinicalTrials.gov10/4/2022·10/04/22🌐 USA
Summary
This Phase 2 feasibility study evaluates the RNS System for thalamocortical brain-responsive neurostimulation in patients with Lennox-Gastaut syndrome, a severe form of drug-resistant epilepsy. The implantable device continuously monitors brain activity and delivers targeted electrical stimulation in response to detected seizure precursors.
Why it matters
Lennox-Gastaut syndrome affects approximately 50,000 children and adults in the US with limited treatment options. Responsive neurostimulation targeting the thalamus represents a novel approach for generalized seizures that could significantly reduce seizure burden in this challenging population.
#Phase 2#Epilepsy#Closed-Loop#Neurostimulation#Neural Interfaces#Neural Recording#Neuroprosthetics#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in